3 results
The aim of the investigation is to demonstrate that the ATB System provides an improvement in hearing outcomes and quality of life compared to unaided hearing in patients with a conductive or mixed hearing loss or single-sided sensorineural deafness…
To evaluate whether Telisotuzumab Vedotin improves response rate and survival in participants who are c-Met+ with NSCLC. For the additional monotherapy cohort :Primary objective is to evaluate the safety and tolerability of telisotuzumab vedotin…
The purpose of this study is to determine if telisotuzumab vedotin works better than docetaxel and to assess how safe telisotuzumab vedotin is in adult participants with NSCLC who have previously been treated. Change in disease activity and adverse…